DAILY MORNING NOTE | 11 October 2023

Local shares closed Tuesday (Oct 10) with a solid rally, as investors around the world took to equity markets with renewed optimism after the initial shocks of the Israeli conflict. DBS was the top gainer – up 1.2 per cent or S$0.39 at S$33.97. The other two lenders were also among the biggest gainers for the day. UOB rose 1 per cent or S$0.29 to S$28.56, while OCBC gained 0.9 per cent or S$0.12 to S$13.00. Nio was the biggest loser for the day, shedding 1.1 per cent or US$0.09 to US$8.49. Venture Corporation was another notable decliner, falling 0.6 per cent or S$0.07 to S$12.27.

Wall Street stocks notched a third straight day of gains on Tuesday as bond yields eased from recent highs, while markets monitored risks from the Israel-Hamas war. The closely watched 10-year US Treasury note yield, which is used to price loans and mortgages, fell further on hints from Federal Reserve officials that they may be done hiking interest rates. Elevated long-term interest rates could mean there is “less need” for another rate hike, Dallas Fed President Lorie Logan said Monday. The Dow Jones Industrial Average finished the day up 0.4 per cent at 33,739.30. The broad-based S&P 500 added 0.5 per cent to close at 4,358.24, while the tech-rich Nasdaq Composite Index advanced 0.6 per cent to 13,562.84.

Top gainers & losers





The closing date for the offer to acquire and delist Healthway Medical has been extended to 5.30pm on Oct 26. As at 6pm on Tuesday (Oct 10), OUE Healthcare and its concert parties had a resultant shareholding of about 65.3 per cent of the total number of Healthway Medical shares. The exit offer price remains at 4.8 cents per share and the offeror – OUEH Investments, the special-purpose vehicle incorporated for the purpose of the exit offer – does not intend to revise it “under any circumstances”. On Tueday, OUEH Investments reminded shareholders that the offer for Healthway Medical was declared unconditional in all respects on Sep 28, and that the company would be delisted subject to the approval of the Singapore Exchange, regardless of the level of acceptances of the exit offer.

US credit rating agency Equifax is now the anchor tenant for Keppel real estate investment trust’s (Reit) new Blue & William office development located in North Sydney, its manager said on Tuesday (Oct 10). Equifax occupies more than 4,350 square metres across the fifth and seventh levels of the property, which is a third of the building’s net lettable area. It moved from two separate offices in the North Sydney area. The manager noted that almost half of Blue & William’s office space has been leased. Other tenants include Northbrew Cafe and global consulting firm Human Synergistics, which will move in early next year. Keppel Reit acquired Blue & William in December 2021. The 10-storey development is located at the intersection of Blue Street and William Street. Lendlease is the development and investment manager.

Restaurant operator No Signboard Holdings’ board has appointed Lim Teck-Ean as interim chief executive officer to oversee the group’s strategic direction, corporate development and investor relations. The current executive chairman and chief executive, Sam Lim, faces charges of share price rigging under the Securities and Futures Act. If convicted, he may be jailed for up to seven years or fined up to S$250,000, or both. On Tuesday (Oct 10), No Signboard said: “The board of directors reviewed and considered Lim Teck-Ean’s qualifications, working experience, capabilities and ability to contribute to the company and other relevant factors.” Lim Teck-Ean will also be designated executive director of the company. Prior to his appointment, the 48-year-old was one of the beneficial owners of Gazelle Ventures, an entity which had invested in No Signboard. Gazelle is expected to hold 75 per cent shareholding interest in the enlarged share capital of No Signboard upon completion of the investment. Lim has since stepped down as CEO of Gazelle.


Boeing deliveries of its best-selling 737 MAX fell to the lowest level since August 2021, as it continues to struggle with work needed to correct a manufacturing defect. The largest US planemaker said on Tuesday (Oct 10) overall deliveries fell to 27 in September, including 15 Boeing MAX 8 and 9 airplanes, the fourth-lowest month of MAX deliveries since deliveries resumed in December 2020 after a worldwide grounding following two MAX crashes in 2018 and 2019 that killed 346 people. Boeing is undergoing an extensive process used to inspect and fix thousands of misdrilled holes on the 737 MAX 8 aft pressure bulkhead. The planemaker booked new orders in September for 224 planes and reported 10 cancellations. The new orders include 50 787s for United Airlines. Overall, Boeing has handed over 371 planes to customers during the first nine months of 2023, including 286 737s. By comparison, European rival Airbus has delivered 488 aircraft over the first eight months, including 55 in September.

AMD said on Tuesday (Oct 10) it plans to buy an artificial intelligence startup called Nod.ai as part of an effort to bolster its software capabilities. In its race to catch rival chipmaker Nvidia, Advanced Micro Devices plans to invest heavily in the critical software necessary for the company’s advanced AI chips. Through more than a decade of work, Nvidia has built a powerful advantage in the AI chip market through the software it makes, and the software developer ecosystem. AMD has vowed to invest in and build a unified collection of software to power the various chips the company makes. The acquisition of Nod.ai fits into the strategy because its technology enables companies to deploy AI models that are tuned for AMD’s chips more easily. Nod.ai sells its technology to large data centre operators, among other customers. AMD did not disclose the terms of the deal.

Adobe on Tuesday (Oct 10) said it is rolling out new image-generation technology that can draw inspiration from an uploaded image and match its style, in its latest push to compete with startups challenging its core business. Image-generating technology from firms like Midjourney and Stable Diffusion have threatened Adobe’s customer base of creative professionals who use its tools like Photoshop. Adobe, which has promised its customers that generated images will be safe from legal challenges, said those customers have used the tools to generate three billion images, a billion of them in the last month alone. The new generation of tools announced on Tuesday will include a feature called “Generative Match”. Like Adobe’s earlier tool, it will allow users to generate an image from a few words of text. But it will also allow users to upload as few as 10 to 20 images to use as a basis for the generated images.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


PSR Stocks Coverage



For more information, please visit:


Upcoming Webinars

Strategy & Stock Picks (US Market)

Date & Time: 12 Oct 2023 | 7.30pm – 9pm

Register: https://tinyurl.com/ycy2ezwu

Guest Presentation by Keppel Pacific Oak US REIT (KORE)

Date & Time: 19 Oct 2023 | 12pm – 1pm

Register: http://tinyurl.com/5n8kh8ta

Corporate Insights by Sasseur REIT [NEW]

Date & Time: 15 Nov 2023 | 12pm – 1pm

Register: https://tinyurl.com/464ndms7

POEMS Podcast:

Research Videos

Singapore Equity 4Q23 Strategy
Date: 9 October 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.


Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!


The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com